Trial Profile
Pulse photodynamic therapy with methyl aminolevulinate activated by a halogen lamp Puls-fotodynamisk terapi med methylaminolevulinat aktiveret ved halogenlampe
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 01 Dec 2016
Price :
$35
*
At a glance
- Drugs Methyl aminolevulinate (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- 01 Dec 2016 This trial was discontinued in Denamrk (end date: 2014-04-01), according to European Clinical Trials Database.
- 28 Jul 2014 New trial record